Viewing nowPencilim Tablets (Phendimetrazine Tartrate)
Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

MFDS item code 200707106 · Approved 2007.06.20
Weight loss adjunct therapy for patients with obesity (high body mass index and risk factors)
This medication is used to assist weight loss in obese patients with a body mass index (BMI) over 30 or patients with a BMI over 27 who have risk factors such as hypertension, diabetes, or dyslipidemia, who do not respond to appropriate dietary and exercise regimens. It should be taken alone, without combining with other appetite suppressants, as a short-term adjunct to caloric restriction-based weight loss therapy. Specifically, this medication plays a supportive role in the treatment of exogenous obesity, aiding in the restoration of health and weight control for the patient.
Administer 35 mg orally, 2 to 3 times a day, 1 hour before meals. Use the minimal effective dose, adjusting for each individual as necessary. For some patients, 17.5 mg once daily may be appropriate. Do not exceed 70 mg per dose and 3 times a day. The treatment duration is short-term (within 4 weeks). If there is a weight loss of at least 1.8 kg within the first 4 weeks, treatment may be continued.
This medication should only be used alone for a short period, as serious heart problems may occur when used with other appetite suppressants. Prolonged use of this medication may significantly increase the risk of a serious lung condition called pulmonary hypertension; therefore, if symptoms such as shortness of breath or chest pain occur, use should be discontinued immediately, and evaluation should be sought. It's important to check heart conditions before administration due to potential associations with valvular heart disease; it is advisable not to use it in patients with heart problems or murmurs. Individuals with certain heart diseases, hypertension, hyperthyroidism, glaucoma, mental instability, or a history of substance abuse should not use this medication. Children under 16 years of age and women who are pregnant or may become pregnant should also not take this medication. Patients with mild hypertension, diabetes, or nursing mothers should exercise particular caution while using this medication, and individuals with diabetes may need to adjust their insulin doses. This medication may cause increased heart rate or blood pressure, and a variety of side effects such as anxiety, insomnia, dizziness, dry mouth, and digestive disorders can occur. Tolerance may develop, leading to reduced effectiveness; therefore, do not increase the dose and discontinue use. Caution is needed when engaging in hazardous activities such as driving or operating machinery. In case of overdose, severe central nervous system and cardiovascular symptoms may occur, requiring immediate appropriate treatment at a hospital. Keep out of the reach of children; this medication is classified as a narcotic and should not be abused without a doctor's prescription.
Urticaria, peripheral edema, increased risk of pulmonary hypertension leading to exercise-induced dyspnea, angina symptoms, syncope, valvular heart disease, potential occurrence of severe heart disease, coma and seizures with overdose, increased respiration, oppositional symptoms, confusion, aggression, panic state, arrhythmia, hypertension, hypotension, circulatory collapse
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from exposure to air and moisture. It is important to maintain the storage temperature between 1 degree Celsius and 30 degrees Celsius.
White round tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPhendimetrazine Tartrate 35mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Albuzene Korea Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Joah Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Bionex Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
PharmGen Science Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Dae Won Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.